265 related articles for article (PubMed ID: 16126052)
1. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
3. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
Stempel DA; Kruzikas DT; Manjunath R
J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894
[TBL] [Abstract][Full Text] [Related]
5. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
[TBL] [Abstract][Full Text] [Related]
8. Adherence to asthma controller medication regimens.
Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[TBL] [Abstract][Full Text] [Related]
9. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
13. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
Stempel DA; Mauskopf J; McLaughlin T; Yazdani C; Stanford RH
Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
16. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[TBL] [Abstract][Full Text] [Related]
17. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
Renzi PM; Howard LA; Ortega HG; Ahmad FF; Chapman KR
Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[TBL] [Abstract][Full Text] [Related]
19. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
